Literature DB >> 26561730

Cell density regulates cancer metastasis via the Hippo pathway.

Ghada M Sharif1, Anton Wellstein1.   

Abstract

Metastatic spread of cancer cells from the primary tumor site to distant organs is the major cause of death in cancer patients. To disseminate, cancer cells detach from the primary tumor, enter the blood stream and extravasate at distant organ sites such as the liver, lung, bone or brain. While cancer cells are known to evade contact inhibition during growth in culture, we found that cell density is still sensed and can signal through the Hippo pathway effectors LATS1 and YAP. These effectors control cancer cell invasive behavior into stromal tissues, expression of cytokines that recruit inflammatory cells and progression toward metastatic spread. In this perspective, we discuss the drivers and the significance of pathways controlled by cell growth density.

Entities:  

Keywords:  Hippo pathway; cell density; cytokine signaling; vascular invasion

Mesh:

Substances:

Year:  2015        PMID: 26561730      PMCID: PMC4976833          DOI: 10.2217/fon.15.268

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  44 in total

Review 1.  The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease.

Authors:  Xaralabos Varelas
Journal:  Development       Date:  2014-04       Impact factor: 6.868

Review 2.  Regulation of the Hippo pathway and implications for anticancer drug development.

Authors:  Hyun Woo Park; Kun-Liang Guan
Journal:  Trends Pharmacol Sci       Date:  2013-09-16       Impact factor: 14.819

3.  IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells.

Authors:  Romaine I Fernando; Marianne D Castillo; Mary Litzinger; Duane H Hamilton; Claudia Palena
Journal:  Cancer Res       Date:  2011-06-08       Impact factor: 12.701

Review 4.  Hippo pathway regulation of gastrointestinal tissues.

Authors:  Fa-Xing Yu; Zhipeng Meng; Steven W Plouffe; Kun-Liang Guan
Journal:  Annu Rev Physiol       Date:  2014-09-29       Impact factor: 19.318

Review 5.  The emerging roles of YAP and TAZ in cancer.

Authors:  Toshiro Moroishi; Carsten Gram Hansen; Kun-Liang Guan
Journal:  Nat Rev Cancer       Date:  2015-01-16       Impact factor: 60.716

6.  YAP1 takes over when oncogenic K-Ras slumbers.

Authors:  Florian R Greten
Journal:  Cell       Date:  2014-07-03       Impact factor: 41.582

7.  Paracrine signaling between carcinoma cells and mesenchymal stem cells generates cancer stem cell niche via epithelial-mesenchymal transition.

Authors:  Kati Räsänen; Meenhard Herlyn
Journal:  Cancer Discov       Date:  2012-09       Impact factor: 39.397

8.  Tumor self-seeding by circulating cancer cells.

Authors:  Mi-Young Kim; Thordur Oskarsson; Swarnali Acharyya; Don X Nguyen; Xiang H-F Zhang; Larry Norton; Joan Massagué
Journal:  Cell       Date:  2009-12-24       Impact factor: 41.582

9.  Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis.

Authors:  Allison N Lau; Stephen J Curtis; Christine M Fillmore; Samuel P Rowbotham; Morvarid Mohseni; Darcy E Wagner; Alexander M Beede; Daniel T Montoro; Kerstin W Sinkevicius; Zandra E Walton; Juliana Barrios; Daniel J Weiss; Fernando D Camargo; Kwok-Kin Wong; Carla F Kim
Journal:  EMBO J       Date:  2014-02-04       Impact factor: 11.598

10.  Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma.

Authors:  Flore Nallet-Staub; Véronique Marsaud; Ling Li; Cristèle Gilbert; Sophie Dodier; Véronique Bataille; Marius Sudol; Meenhard Herlyn; Alain Mauviel
Journal:  J Invest Dermatol       Date:  2013-07-29       Impact factor: 8.551

View more
  8 in total

1.  Mechanical coordination is sufficient to promote tissue replacement during metamorphosis in Drosophila.

Authors:  Carla Prat-Rojo; Philippe-Alexandre Pouille; Javier Buceta; Enrique Martin-Blanco
Journal:  EMBO J       Date:  2019-12-20       Impact factor: 11.598

2.  Cooperativity between stromal cytokines drives the invasive migration of human breast cancer cells.

Authors:  Yair Elisha; Yael Sagi; Georg Klein; Ravid Straussman; Benjamin Geiger
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-07-01       Impact factor: 6.237

3.  Construction and evaluation of detachable bone-targeting MOF carriers for the delivery of proteasome inhibitors.

Authors:  Hongbing Yang; Zhenyan Yu; Shuaishuai Ji; Jie Yan; Lei Han; Yang Liu; Yanjuan Wang; Yimin Niu; Qiang Huo; Ming Xu
Journal:  RSC Adv       Date:  2022-05-16       Impact factor: 4.036

4.  Lappaol F, an anticancer agent, inhibits YAP via transcriptional and post-translational regulation.

Authors:  Xiao Li; Yi-Ying Lin; Jia-Yi Tan; Kang-Lun Liu; Xiao-Ling Shen; Ying-Jie Hu; Rui-Yi Yang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

5.  Yes-associated protein 1 is required for proliferation and function of bovine granulosa cells in vitro†.

Authors:  Michele R Plewes; Xiaoying Hou; Pan Zhang; Aixin Liang; Guohua Hua; Jennifer R Wood; Andrea S Cupp; Xiangmin Lv; Cheng Wang; John S Davis
Journal:  Biol Reprod       Date:  2019-11-21       Impact factor: 4.161

6.  Mammalian Eps15 homology domain 1 promotes metastasis in non-small cell lung cancer by inducing epithelial-mesenchymal transition.

Authors:  Qingwei Meng; Ying Xing; Tingting Ren; Hailing Lu; Yuhui Xi; Zhijun Jiang; Jing Hu; Chunhong Li; Lichun Sun; Dianjun Sun; Li Cai
Journal:  Oncotarget       Date:  2017-04-04

7.  Suppression of YAP by DDP disrupts colon tumor progression.

Authors:  Kun Li; Jiwei Guo; Yan Wu; Dan Jin; Hong Jiang; Chengxia Liu; Chengyong Qin
Journal:  Oncol Rep       Date:  2018-03-06       Impact factor: 3.906

8.  Downregulation of NDR1 contributes to metastasis of prostate cancer cells via activating epithelial-mesenchymal transition.

Authors:  Juntao Yue; Huimin Sun; Shijie Liu; Fei Yu; Shanshan Wang; Fuli Wang; Ruixiong Shen; Feng Zhu; Lei Zhang; Chen Shao
Journal:  Cancer Med       Date:  2018-05-07       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.